{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T19:43:16Z","timestamp":1775504596131,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NR-624"],"award-info":[{"award-number":["NR-624"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NR-56"],"award-info":[{"award-number":["NR-56"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ijbiomac.2026.150733","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:55:09Z","timestamp":1770134109000},"page":"150733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["MPXV protein scaffold cum antigen-based macromolecular multi-antigen displaying next-generation vaccine, providing coordinated humoral and cellular response"],"prefix":"10.1016","volume":"347","author":[{"given":"Ankit","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyasi","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puneet","family":"Srivastva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anurag","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravishankar","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tripti","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.150733_bb0005","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.3389\/fimmu.2020.02130","article-title":"Viral emerging diseases: challenges in developing vaccination strategies","volume":"11","author":"Trovato","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.150733_bb0010","author":"Organization WH"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.150733_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/v17060753","article-title":"Mpox 2022 to 2025 update: a comprehensive review on its complications, transmission, diagnosis, and treatment","volume":"17","author":"Yadav","year":"2025","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.150733_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.70102","article-title":"Monkeypox outbreak in the Democratic Republic of Congo: a comprehensive review of clinical outcomes, public health implications, and security measures","volume":"12","author":"Salomon","year":"2024","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.ijbiomac.2026.150733_bb0025","doi-asserted-by":"crossref","unstructured":"Mohapatra RK, Kandi V, Seidel V, Sarangi AK, Mishra S, Rabaan AA, et al. Monkeypox lineages amid the ongoing COVID-19 pandemic: a global public health concern - correspondence Int. J. Surg. 2022 Nov;107:106968. PubMed PMID: 36330989. Pubmed Central PMCID: 9617653.","DOI":"10.1016\/j.ijsu.2022.106968"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.150733_bb0030","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/s41591-022-01907-y","article-title":"Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus","volume":"28","author":"Isidro","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2026.150733_bb0035","doi-asserted-by":"crossref","unstructured":"Srivastava S, Laxmi, Sharma K, Sridhar SB, Talath S, Shareef J, et al. Clade Ib: a new emerging threat in the Mpox outbreak. Front. Pharmacol. 2024;15:1504154. PubMed PMID: 39749207. Pubmed Central PMCID: 11693458.","DOI":"10.3389\/fphar.2024.1504154"},{"key":"10.1016\/j.ijbiomac.2026.150733_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2024.105662","article-title":"Human monkeypox virus: epidemiologic review and research progress in diagnosis and treatment","volume":"171","author":"Sun","year":"2024","journal-title":"J. Clin. Virol."},{"issue":"19","key":"10.1016\/j.ijbiomac.2026.150733_bb0045","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of humoral immunity to common viral and vaccine antigens","volume":"357","author":"Amanna","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150733_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2009.06.006","article-title":"Vaccinia virus vaccines: past, present and future","volume":"84","author":"Jacobs","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijbiomac.2026.150733_bb0055","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.virol.2015.03.032","article-title":"Live attenuated vaccines: historical successes and current challenges","volume":"479-480","author":"Minor","year":"2015","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.150733_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2025.101098","article-title":"The impact of orthopoxvirus vaccination and Mpox infection on cross-protective immunity: a multicohort observational study","volume":"6","author":"Crandell","year":"2025","journal-title":"Lancet Microbe."},{"key":"10.1016\/j.ijbiomac.2026.150733_bb0065","article-title":"Human monkeypox - after 40 years, an unintended consequence of smallpox eradication","volume":"10","author":"Shah","year":"2022","journal-title":"Front. Public Health"},{"issue":"37","key":"10.1016\/j.ijbiomac.2026.150733_bb0070","doi-asserted-by":"crossref","first-page":"16262","DOI":"10.1073\/pnas.1005769107","article-title":"Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo","volume":"107","author":"Rimoin","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"25","key":"10.1016\/j.ijbiomac.2026.150733_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.06.021","article-title":"Vaccine effectiveness of 3rd generation mpox vaccines against mpox and disease severity: a systematic review and meta-analysis","volume":"42","author":"Pischel","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2026.150733_bb0080","author":"Organization wH"},{"key":"10.1016\/j.ijbiomac.2026.150733_bb0085","unstructured":"N. Okumura, E. Morino, H. Nomoto, M. Yanagi, K. Takahashi, H. Iwasaki, et al., LC16m8 for pre-exposure prophylaxis against Mpox in a high-risk population: an open-label randomized trial, Clin. Infect. Dis. 12 (Suppl 1), ofae631.1571. (PubMed PMID: 39982831)."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150733_bb0090","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1128\/CVI.00782-14","article-title":"Use of the LC16m8 smallpox vaccine in immunocompromised individuals is still too risky","volume":"22","author":"Danon","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"issue":"20","key":"10.1016\/j.ijbiomac.2026.150733_bb0095","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1817307","article-title":"Phase 3 efficacy trial of modified vaccinia Ankara as a vaccine against smallpox","volume":"381","author":"Pittman","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2026.150733_bb0100","series-title":"WHO Adds LC16m8 Mpox Vaccine to Emergency Use Listing","author":"Organization WH","year":"2024"},{"key":"10.1016\/j.ijbiomac.2026.150733_bb0105","author":"Prevention CfDCa"},{"key":"10.1016\/j.ijbiomac.2026.150733_bb0110","doi-asserted-by":"crossref","unstructured":"Kugelman JR, Johnston SC, Mulembakani PM, Kisalu N, Lee MS, Koroleva G, et al. Genomic variability of monkeypox virus among humans, Democratic Republic of the Congo. Emerg. Infect. Dis. 2014 Feb;20(2):232\u20139. PubMed PMID: 24457084. Pubmed Central PMCID: 3901482.","DOI":"10.3201\/eid2002.130118"},{"key":"10.1016\/j.ijbiomac.2026.150733_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102855","article-title":"The 2022 outbreak and the pathobiology of the monkeypox virus","volume":"131","author":"Kumar","year":"2022","journal-title":"J. Autoimmun."},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.150733_bb0120","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.1128\/JVI.00353-08","article-title":"Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice","volume":"82","author":"Kaufman","year":"2008","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.150733_bb0125","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/nm1457","article-title":"Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination","volume":"12","author":"Putz","year":"2006","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.150733_bb0130","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1080\/14760584.2016.1205492","article-title":"Manufacturing DTaP-based combination vaccines: industrial challenges around essential public health tools","volume":"15","author":"Vidor","year":"2016","journal-title":"Expert Rev. Vaccines"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.150733_bb0135","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4161\/hv.23220","article-title":"Applications and challenges of multivalent recombinant vaccines","volume":"9","author":"Naim","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.150733_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9090964","article-title":"Simultaneous immunization with multiple diverse immunogens alters development of antigen-specific antibody-mediated immunity","volume":"9","author":"Pilewski","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.ijbiomac.2026.150733_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106156","article-title":"Progress and prospects on vaccine development against monkeypox infection","volume":"180","author":"Saadh","year":"2023","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ijbiomac.2026.150733_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105974","article-title":"An mpox quadrivalent mRNA vaccine protects mice from lethal vaccinia virus challenge","volume":"230","author":"Li","year":"2024","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.150733_bb0155","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41590-023-01715-7","article-title":"Rational design of a \u2018two-in-one\u2019 immunogen DAM drives potent immune response against mpox virus","volume":"25","author":"Wang","year":"2024","journal-title":"Nat. Immunol."},{"issue":"19","key":"10.1016\/j.ijbiomac.2026.150733_bb0160","doi-asserted-by":"crossref","first-page":"11339","DOI":"10.1128\/JVI.01491-14","article-title":"Potent neutralization of vaccinia virus by divergent murine antibodies targeting a common site of vulnerability in L1 protein","volume":"88","author":"Kaever","year":"2014","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.150733_bb0165","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.0501103102","article-title":"The 1.51-Angstrom structure of the poxvirus L1 protein, a target of potent neutralizing antibodies","volume":"102","author":"Su","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.150733_bb0170","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.virol.2007.06.042","article-title":"Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein","volume":"368","author":"Su","year":"2007","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150733_bb0175","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001716","article-title":"The crystal structure of vaccinia virus protein E2 and perspectives on the prediction of novel viral protein folds","volume":"103","author":"Gao","year":"2022","journal-title":"J. Gen. Virol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150733_bb0180","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1462-5822.2009.01296.x","article-title":"An E2-F12 complex is required for intracellular enveloped virus morphogenesis during vaccinia infection","volume":"11","author":"Dodding","year":"2009","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.ijbiomac.2026.150733_bb0185","doi-asserted-by":"crossref","unstructured":"Matho MH, Schlossman A, Meng X, Benhnia MR, Kaever T, Buller M, et al. Structural and functional characterization of anti-A33 antibodies reveal a potent cross-species orthopoxviruses neutralizer. PLoS Pathog. 2015 Sep;11(9):e1005148. PubMed PMID: 26325270. Pubmed Central PMCID: 4556652.","DOI":"10.1371\/journal.ppat.1005148"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150733_bb0190","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1128\/JVI.02247-09","article-title":"The structure of the poxvirus A33 protein reveals a dimer of unique C-type lectin-like domains","volume":"84","author":"Su","year":"2010","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.150733_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/v17020186","article-title":"Approaches to next-generation capripoxvirus and monkeypox virus vaccines","volume":"17","author":"Williamson","year":"2025","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.150733_bb0200","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.vaccine.2006.10.009","article-title":"A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost","volume":"25","author":"Xiao","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150733_bb0205","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2192815","article-title":"Rational development of multicomponent mRNA vaccine candidates against mpox","volume":"12","author":"Zhang","year":"2023","journal-title":"Emerg. Microbes Infect."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150733_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines13050514","article-title":"A single-chain Mpox mRNA vaccine elicits protective immune response in mice","volume":"13","author":"Xu","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.ijbiomac.2026.150733_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105392","article-title":"Single-chain A35R-M1R-B6R trivalent mRNA vaccines protect mice against both mpox virus and vaccinia virus","volume":"109","author":"Kong","year":"2024","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150733_bb0220","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2204151","article-title":"Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge","volume":"12","author":"Zeng","year":"2023","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.ijbiomac.2026.150733_bb0225","doi-asserted-by":"crossref","unstructured":"Li J, Liu Y, Dai J, Yang L, Xiong F, Xia J, et al. mRNA vaccines: current applications and future directions. MedComm 2025 Nov;6(11):e70434. PubMed PMID: 41179708. Pubmed Central PMCID: 12572956.","DOI":"10.1002\/mco2.70434"},{"key":"10.1016\/j.ijbiomac.2026.150733_bb0230","doi-asserted-by":"crossref","unstructured":"Chen S, Pounraj S, Sivakumaran N, Kakkanat A, Sam G, Kabir MT, et al. Precision-engineering of subunit vaccine particles for prevention of infectious diseases. Front. Immunol. 2023;14:1131057. PubMed PMID: 36817419. Pubmed Central PMCID: 9935699.","DOI":"10.3389\/fimmu.2023.1131057"},{"key":"10.1016\/j.ijbiomac.2026.150733_bb0235","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature 2021 Aug;596(7873):583\u20139. PubMed PMID: 34265844. Pubmed Central PMCID: 8371605 have filed non-provisional patent applications 16\/701,070 and PCT\/EP2020\/084238, and provisional patent applications 63\/107,362, 63\/118,917, 63\/118,918, 63\/118,921 and 63\/118,919, each in the name of DeepMind Technologies Limited, each pending, relating to machine learning for predicting protein structures. The other authors declare no competing interests."},{"key":"10.1016\/j.ijbiomac.2026.150733_bb0240","doi-asserted-by":"crossref","unstructured":"Shrivastava T, Singh B, Rizvi ZA, Verma R, Goswami S, Vishwakarma P, et al. Comparative immunomodulatory evaluation of the receptor binding domain of the SARS-CoV-2 spike protein; a potential vaccine candidate which imparts potent humoral and Th1 type immune response in a mouse model. Front. Immunol. 2021;12:641447. PubMed PMID: 34108961. Pubmed Central PMCID: 8182375.","DOI":"10.3389\/fimmu.2021.641447"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026006598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026006598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:02:59Z","timestamp":1772168579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026006598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":48,"alternative-id":["S0141813026006598"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150733","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MPXV protein scaffold cum antigen-based macromolecular multi-antigen displaying next-generation vaccine, providing coordinated humoral and cellular response","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150733","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150733"}}